Fibrinogen is an independent marker for thoracic aortic atherosclerosis.

[1]  P C Elwood,et al.  Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. , 1996, European heart journal.

[2]  M. Enriquez-Sarano,et al.  Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. , 1996, The New England journal of medicine.

[3]  B. Gromoll,et al.  Aortic atherosclerotic plaques as a source of systemic embolism. , 1996, Journal of the American College of Cardiology.

[4]  A. Evans,et al.  β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction , 1996 .

[5]  D. Arveiler,et al.  Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. , 1996, Circulation.

[6]  A. Simon,et al.  Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[7]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[8]  W. Shen,et al.  Noninvasive prediction of coronary artery disease by transesophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease. , 1994, The American journal of cardiology.

[9]  M. Hori,et al.  Evaluation of thoracic aortic atherosclerosis by transesophageal echocardiography. , 1994, American heart journal.

[10]  G. Assmann,et al.  Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  W. Wijns,et al.  Regional wall motion abnormalities in stunned and hibernating myocardium. , 1993, European heart journal.

[12]  E. Ernst,et al.  Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.

[13]  E. Ernst.  Lowering the plasma fibrinogen concentration with drugs. , 1992, Clinical pharmacy.

[14]  M. Matsuzaki,et al.  Advances in transesophageal echocardiography for the evaluation of atherosclerotic lesions in thoracic aorta--the effects of hypertension, hypercholesterolemia, and aging on atherosclerotic lesions. , 1992, Japanese circulation journal.

[15]  W. Koenig,et al.  The possible role of hemorheology in atherothrombogenesis. , 1992, Atherosclerosis.

[16]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[17]  A Hofman,et al.  Aortic calcified plaques and cardiovascular disease (the Framingham Study). , 1990, The American journal of cardiology.

[18]  R. D'Agostino,et al.  Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. , 1990, American heart journal.

[19]  J. Sasaki,et al.  Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. , 1989, Atherosclerosis.

[20]  V. Nguyen.  Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .

[21]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[22]  E. Ernst,et al.  Dose—effect relationship between smoking and blood rheology , 1987, British journal of haematology.

[23]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[24]  E. Ernst,et al.  Abstention from chronic cigarette smoking normalizes blood rheology. , 1987, Atherosclerosis.

[25]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[26]  E. Ernst,et al.  Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. , 1986, Atherosclerosis.

[27]  D. Ramsdale,et al.  Angina, coronary risk factors and coronary artery disease in patients with valvular disease. A prospective study. , 1984, European heart journal.

[28]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[29]  T. Meade,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE , 1981, The Lancet.

[30]  S Chien,et al.  Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. , 1981, The American journal of medicine.

[31]  C. Forbes,et al.  Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia , 1979, Thrombosis and Haemostasis.

[32]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[33]  J. Dormandy,et al.  Clinical, Haemodynamic, Rheological, and Biochemical Findings in 126 Patients with Intermittent Claudication , 1973, British medical journal.

[34]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .